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Proteomic studies have suggested a biochemical interaction between𝛼 subunit of the large conductance, voltage- andCa2+-activated
potassium channel (BKCa𝛼), and annexin A5 (ANXA5), which we verify here by coimmunoprecipitation and double labelling
immunocytochemistry. The observation that annexin is flipped to the outer membrane leaflet of the plasma membrane during
apoptosis, together with the knowledge that the intracellular C-terminal of BKCa𝛼 contains both Ca
2+-binding and a putative
annexin-bindingmotif, prompted us to investigate the functional consequences of this protein partnership to cell death.Membrane
biotinylation demonstrated that ANXA5 was flipped to the outer membrane leaflet of HEK 293 cells early in serum deprivation-
evoked apoptosis. As expected, serum deprivation caused caspase-3/7 activation and this was accentuated in BKCa𝛼 expressing
HEK 293 cells.The functional consequences of ANXA5 partnership with BKCa𝛼were striking, with ANXA5 knockdown causing an
increase andANXA5 overexpression causing a decrease, in single BKCa channel Ca
2+-sensitivity, measured in inside-outmembrane
patches by patch-clamp. Taken together, these data suggest a novel model of the early stages of apoptosis where membrane flippage
results in removal of the inhibitory effect of ANXA5 on K+ channel activity with the consequent amplification of Ca2+ influx and
augmented activation of caspases.
1. Introduction
Programmed cell death (apoptosis) is a series of controlled
events which, when balanced with cell proliferation, is essen-
tial for the normal development of tissue and function of
cells. Disturbing this equilibrium is a contributory factor in
a number of disease states, such as neurodegenerative disor-
ders, pulmonary hypertension, and cancer [1–3]. Apoptosis
occurs in three main steps: (i) the initiation event when
the signal for a cell to apoptosis is received and the cell
begins to shrink, due to loss of cell volume; (ii) the effector
phase when the mitochondrial membrane potential becomes
depolarized, the mitochondrial transition pore opens, and
the release of cytochrome C and other large molecules from
the mitochondrial matrix results in activation of caspases;
and (iii) the last phase in which DNA becomes degraded,
apoptotic bodies excise from the plasma membrane, and
the cytoskeleton is broken down (see [4] for review). As
part of this process, phosphatidylserine is translocated from
the inner (cytoplasmic) leaflet of the plasma membrane to
the outer (cell surface) leaflet soon after the induction of
apoptosis (“flippage”), where proteins such as the annexins
are known to bind with high affinity [5]. This flippage
phenomenon is utilized in diagnostic tests for apoptosis.
However, little evidence exists as to how and when flippage
occurs and what are the consequences that this process has
for the apoptosis cascade.
K+ fluxes have been shown to play an important role
in both the early and late phases of apoptosis [4]. Once
apoptosis is triggered, one of the earliest observed morpho-
logical changes is cell shrinkage or apoptotic volume decrease
(AVD). This is due to the efflux of K+ and Cl− ions through
their respective channels that leads to water exiting the
cell through aquaporin water channels in order to maintain
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the osmotic pressure balance between internal and external
compartments. Identification of the specific K+ channels,
which are involved in apoptotic volume decrease, has
employed pharmacological agents; to date, evidence suggests
that all themajor classes of K+ channels (voltage-gated, Ca2+-
activated, ATP-sensitive, inwardly rectifying, and two pore
domain K+ channels) have some role to play in apoptosis
[8–12]. Blockage of the large conductance and voltage- and
calcium-activated potassium channel (BKCa) by iberiotoxin
or tetraethylammonium (TEA) inhibits carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP, amitochondrial
protonophore) induced apoptosis in both rat and human
pulmonary smooth muscle cells [13]. Other studies indicate
that the application of NS1619, a specific BKCa channel opener
which can induce apoptosis in ovarian cancer cells [14]
and exposure of erythrocytes to ionomycin (Ca2+ ionophore
which raises internal Ca2+ concentrations ([Ca2+]i)) induces
cell shrinkage and apoptosis via BKCa [15]. During the later
stages of apoptosis, it has been demonstrated that only
cells with a decreased cytosolic concentration of K+ exhibit
caspase activity [16, 17], suggesting that the effluxofK+ during
AVD is permissive for caspase activation during the later
stages of cell death.
The annexins are a structurally related family of Ca2+-
sensitive proteins which participate in a wide range of cel-
lular functions, including cellular signalling, cell migration,
proliferation, and apoptosis [18–21].These proteins have been
shown to interact with a number of ion channels and are
important in both membrane trafficking and modifying of
ion channel function [1, 22, 23]. Using a proteomics-based
approach, which previously identified heme oxygenase-2
(HO-2) as O
2
-sensing protein partner of BKCa, we also iden-
tified ANXA5 as a potential interacting protein of BKCa [24].
A more recent study has shown that this particular protein
partnership also occurs in native tissues, namely, the mouse
cochlea [25]. Based on the knowledge that BKCa channel
activation can induce apoptosis in a number of different
cell types and the fact that annexins bind to externalized
phosphatidylserine in response to apoptosis, we have begun
to investigate how the partnership between ANXA5 and
BKCa might influence this process. It has been proposed that
annexins have a binding affinity for EF-hand Ca2+-binding
proteins and 𝛼-subunit of the human BKCa (KCNMA1) has a
similar domain within its Ca2+ sensing region [26].
The aim of this study was to validate the interaction of
ANXA5 and BKCa𝛼-subunit (BKCa𝛼), which was previously
suggested by proteomics [24], to determine the biophysical
consequences of the BKCa𝛼/ANXA5 partnership, in particu-
lar to elucidate the structural elements required, and to define
the impact of this partnership on apoptosis.
2. Materials and Methods
2.1. Cell Culture. The studies were performed on both wild
type HEK 293 cells and HEK 293 cell line stably express-
ing the human BKCa𝛼 subunit (see [24, 27–31]). HEK 293
cells were maintained in Earle’s minimal essential medium
(containing L-glutamine) supplemented with 10% fetal calf
serum, 1% antibiotic/antimycotic, and 1% nonessential amino
acids (Gibco BRL, Strathclyde, UK) in a humidified incubator
gassed with 5% CO
2
/95% air. Where indicated, apoptosis
was induced by 48 h of serum deprivation (SD). Knockdown
and overexpression of ANXA5 were achieved by transient
transfection of cells with specific siRNA andANXA5 plasmid
DNA, respectively. Transfection was achieved using the
Amaxa Nucleofector Kit V supplied with green fluorescent
protein (GFP) for positive identification of transfected cells,
following the manufacturer’s protocols (Amaxa Biosystems,
Germany). 24 h before performing the electrophysiological
experiments, cells were passaged and plated onto glass cov-
erslips, cultured as above, and then transferred into a con-
tinuously perfused (5mL⋅min−1) recording chamber (volume
ca. 200𝜇L) mounted on the stage of an inverted microscope
equipped with phase-contrast and fluorescent optics for
(Olympus CK40).
2.2. Electrophysiological Recordings. BKCa𝛼 currents were
recorded from inside-out membrane patches excised from
the stably expressing the wild type HEK293 cells, transiently
transfected with the ANXA5 siRNA or the ANXA5 plas-
mid. The pipette and bath solutions contained (in mM)
10 NaCl, 117 KCl, 2 MgCl
2
, 11 N-2-hydroxyethylpiperazine-
N󸀠-2-ethanesulfonic acid (HEPES; pH 7.2) with [Ca2+]o
at 1.2mM and [Ca2+]i adjusted to the quasiphysiologi-
cal level of 300 nM using ethylene-glycol-tetra-acetic acid
(EGTA), except when experiments were performed at
the different range of Ca2+ concentration (10 nM–1mM).
The CO donor molecule, tricarbonyldichlororuthenium (II)
dimer ([Ru(CO
3
)Cl
2
]
2
, Sigma-Aldrich, Poole, Dorset, UK)
(CORM-2), was employed to release free CO in the experi-
mental solution [32].
All recordings were performed at the room temperature
(22 ± 0.5∘C) using an Axopatch 200A amplifier and Digidata
1320A/D interface (Axon Instruments, Forster City, CA,
USA). BKCa𝛼 channel macroscopic currents were recorded
using a protocol of 8 s voltage ramp from −30mV to 120mV,
followed by three, 250ms steps to +40, +60, and +120mV,
repeated at 0.1 Hz.All voltages are reportedwith the respect to
the innermembrane leaflet (–Vp). All recordingswere filtered
with 8-pole Bessel filter at 5 kHz and digitized at 10 kHz.
Half-activation voltages (Va
50
) and half-activation concen-
trations (EC
50
) were obtained from the current-voltage and
concentration-response curves, respectively, and were fitted
using Hill equation. Statistical comparisons were performed
using one-way ANOVA and the differences were considered
significant at the level of 𝑝 < 0.05.
2.3. Caspase Assays. Apoptosis studies were performed using
the Caspase-Glo 3/7 assay system (Promega). HEK 293 BKCa
Cells and HEK 293 BKCa cells transfected with ANXA5
siRNA (see above) were plated into 96-well white walled
plates, in triplicate for each experimental condition. The
following day apoptosis was induced by replacing the media
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with DMEM supplemented with 8% mannitol (serum-
withdrawal media). Cells were then analysed for caspase-3/7
activity at 24-hour and 48-hour time points. Briefly, 100𝜇L of
Caspase-Glo 3/7 reagent was added to each well and the plate
was shaken at 300 rpm for 30 seconds; the plates were then
incubated at room temperature for one hour before being
assayed in a plate reading luminometer (Fluroskan Ascent
FL, Thermo Labsystems). Duplicate plates were seeded at
the start of all our apoptosis experiments; this allowed us to
normalize our luminescence readings to cell count number.
Cell count number was determined by using CyQUANT cell
proliferation assay (Invitrogen), following themanufacturers’
instructions.
2.4. Reciprocal Coimmunoprecipitations. Wild type HEK 293
cells were seeded into T75 flask and grown to about 80%
confluency. The cells were then washed twice with ice cold
PBS before adding 1mL of ice cold RIPA buffer containing
protease inhibitor cocktail (Sigma) to the cells. The cells were
then scrapped from the flask and transferred to a precooled
centrifuge tube and placed on a rocker for 30 minutes at 4∘C.
The lysate was then centrifuged at 14,000×g for 15 minutes
and the supernatant transferred to a fresh tube. Protein G
Dynabeads (Invitrogen) was prepared following the man-
ufacturers’ instructions, 50 𝜇L of prepared Dynabeads was
resuspended in 100 𝜇L citrate phosphate buffer (pH 5), and
either 5 𝜇g of BKCa𝛼 (Alamone) or ANXA5 (Santa Cruz)
antibody was added. The tubes were then incubated with
rotation for 40 minutes at room temperature. Ig-Dynabeads
complex was then washed 3 times in citrate phosphate buffer
(pH 5) containing 0.01% Tween-20 using a magnetic stand
to capture the beads. After the final wash precleared lysate
(protein samples incubated with prepared Dynabeads to
reduce nonspecific binding) was added to Ig-Dynabeads
complex and incubated with rotation for a further hour at
room temperature. The beads were then washed 3 times in
1mL of PBS and the protein complex eluted from the beads
by adding 20𝜇L 0.1M citrate buffer (pH 2-3) and incubating
for 2 minutes. Finally the pH of the eluate was adjusted by
adding 1MTris pH7.5. BKCa andANXA5were detected using
standard western blotting techniques.
2.5. Immunocytochemistry. Recombinant HEK 293 BKCa𝛼
cells were plated onto coverslips for immunostaining. Media
was aspirated from the dishes and cells were fixed with ice
cold methanol for 10 minutes, followed by 3 washes with
PBS. Cells were then blocked with 5% BSA for 1 hour at
room temperature before applying the primary antibodies
in 1% BSA. Both anti-BKCa𝛼 (Alamone) and anti-ANXA5
antibodies were used at 1 : 200 dilution. Antibodies were
incubated overnight at 4∘C with gently rocking followed by
3 washes with PBS. Following the final PBS wash appropriate
TRITC and FITC conjugated secondary antibodies (Alexa)
were added to the cells at a dilution of 1 : 500 and incubated
at room temperature for 2 hours. The cells were washed 3
times with PBS and the coverslip was fixed onto a slide using
VECTASHIELD (containing DAPI) and images taken with
an Olympus BX61 camera (Olympus).
2.6. Surface Biotinylation and Western Blotting. HEK 293
BKCa𝛼 cells were seeded into T75 flasks and incubated for 48
hours in either normal or serum-withdrawal media. Pierces
cell surface protein isolation kit (Thermo Scientific) was
then used to biotinylate and extract cell surface membrane
proteins. Cells were washed twice in ice cold PBS and 10mL
of biotin solution was added to each flask. The flasks were
incubated at 4∘C for 30 minutes on a rocking platform before
terminating the reactions by adding 0.5mL of quenching
solution.Cellswere gently scrapped into solution andpelleted
by centrifugation before being resuspended in lysis solution.
Cells were then incubated on ice for 30 minutes, vortexing
every 5 minutes for 5 seconds. The cell lysate was then
centrifuged at 10,000×g for 2 minutes and the biotin labelled
proteins were isolated from the supernatant using a Neu-
trAvidin agarose column. Protein samples were separated by
electrophoresis on 10% acrylamide gels and annexin A5 was
detected by western blotting using an anti-ANXA5 antibody
purchased from Santa Cruz antibodies.
3. Results
3.1. Interaction and Colocalization of BK
𝐶𝑎
𝛼 with ANXA5.
Although binding of ANXA5 to phosphatidylserine that
results in its exposure to the external leaflet of the plasma
membrane is routinely used as an assay of cell death, little
information is available on the potential role of annexins
in the earlier stages of apoptosis. The effect that serum
deprivation had on ANXA5 protein levels within the cell was
elucidated using western blotting (Figure 1). Western blots
of total lysates of cells incubated for 48 h in either serum-
deprived (SD) or normal medium showed no difference
in total ANXA5 expression levels (Figure 1(a)). However,
western blot of extracts of cells, which had been surface
biotinylated, demonstrated that serum deprivation resulted
in a dramatic rise in the amount of ANXA5 at the outer
membrane leaflet. These data evidently demonstrate that sig-
nificantly increased proportion of ANXA5 becomes exposed
to the outer side of the plasma membrane during the initial
stages of apoptosis. To test directly the extent to which
ANXA5 and BKCa𝛼 channels contribute to the early stages
of apoptosis, caspase-3/7 assays were performed at 24 and
48 h following serum deprivation (Figure 2). Within 24 h
serum deprivation resulted in a significantly larger increase
of caspase-3/7 activation in BKCa𝛼 HEK 293 cells than it
did in the wild type HEK 293 cells; this difference was
maintained up to the 48 h time point.This initial observation
provided a decent evidence that BKCa𝛼 contributed to the
early apoptotic response of HEK 293 cells. In the absence of
serum deprivation the effect of ANXA5 siRNA knockdown
demonstrated by immunocytochemistry (Figure 2(c)) was
to increase significantly the caspase-3/7 activity in BKCa𝛼
HEK 293 cells only (Figure 2(b)). Importantly, when cells
were deprived of serum, ANXA5 knockdown did not affect
further the caspase-3/7 activation of either cell type at 24 h but
induced a dramatic amplification of this apoptotic response at
48 h in BKCa𝛼HEK 293 cells only (Figure 2(d)).
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Figure 1: Serum deprivation-evoked apoptosis results in early localization of ANXA5 to plasma membrane outer leaflet. (a) The total cell
lysates of BKCa𝛼HEK239 cells cultured for 48 h in either normal (Cont) or serum-deprived (SD) media where prepared and western blotted
to quantify the amounts of ANXA5 and 𝛽-actin. (b) HEK 293 cells stably expressing the human BKCa𝛼 subunit where incubated for 48 hours
in before being incubated with biotin reagent. Extracts where prepared and normalized for protein content before the cell surface proteins
were isolated with avidin-agarose beads. ANXA5 was detected on the blot using a specific antibody.
3.2. ANXA5 Modulates BK
𝐶𝑎
𝛼 Channel Function. A direct
protein interaction between ANXA5 and BKCa𝛼 was vali-
dated using reciprocal coimmunoprecipitations of solubilized
membrane proteins (Figure 3(a)) and immunocytochemistry
(Figure 3(b)). The functional consequences of such physical
interactions were then investigated using patch-clamp elec-
trophysiology.
One of the most important physiological characteristics
of BKCa channels is their ability to open in response to
increase of [Ca2+]. KnockdownofANXA5using siRNA (con-
firmed by the immunocytochemistry shown in Figure 2(c))
resulted in a significant leftward shift of Ca2+ concentration-
response curve of BKCa𝛼 channel activity (Figure 4). This
was reflected in a significant change in the mean Va
50
values
(Figure 4 and Table 1), indicating increased Ca2+ sensitivity
of BKCa𝛼. Conversely, overexpression of ANXA5 (by trans-
fection with a mammalian expression plasmid containing
human ANXA5) evoked a significant rightward shift of Ca2+
concentration-response curve (Figure 4) and a change inVa
50
values (Figure 4 and Table 1), indicating a decreased Ca2+
sensitivity. The alterations of Ca2+ sensitivities evoked by
manipulationwithANXA5 expression occurwithin the phys-
iological [Ca2+]i window of between 100 nM and 1 𝜇M. Ca
2+
sensitivities of BKCa𝛼 channels in the cells transfected with
a scrambled siRNA or empty vector were not significantly
different from those of the wild type HEK 293 cells (data are
not illustrated).
The fact that sensitivity of BKCa𝛼 to Ca
2+ was effectively
modulated by ANXA5 expression was also approved by the
observation that the control BKCa𝛼 activity, at the beginning
of each trace in the presence of 300 nM [Ca2+]i, was higher or
lower than normal. Independently of Ca2+ sensitivity relative
activation of BKCa𝛼 by the carbonmonoxide donor CORM-2
(30 𝜇M) was unaffected (Figure 4 and Table 2).
4. Discussion
During the course of the lifetimes many cells of our body
undergo programmed death and replacement by the new
ones; this process is finely tuned by a variety of mechanisms
within the body. However when this strictly controlled cell
death/regeneration is impaired it can lead to the serious
conditions such as AIDS and cancer. The earliest observable
sign that a cell will undergo programmed cell death is cell
shrinkage. This is primarily caused by K+ efflux through
any of a steadily increasing number of K+ channels [8–
12]. One of such K+ channels is BKCa of which activity is
controlled by [Ca2+]i that contributes to both maintenance
of the resting membrane potential and repolarisation phase
after action potential. Here we identify ANXA5 as a protein
which physically communicates with BKCa𝛼. The main aim
of the present research was to understand how these two
proteins interact at the functional level and to determine
whether this interaction might have consequences for cell
death. Previously it was considered that annexins have only
been implicated in the last stage of apoptosis, but our
data show that ANXA5 has a functional role in the earlier
stages of apoptosis when caspases are activated, and this
process is significantly enhanced in the presence of BKCa𝛼.
Based on this new information we propose that during
resting conditions ANXA5 interacts with BKCa𝛼 on the
intracellular side of the membrane; this protein partnership
causes reduction of BKCa𝛼 channels sensitivity to [Ca
2+
]i;
thus ANXA5 has an inhibitory effect on BKCa𝛼 channels’
activity and keeps K+ efflux to the minimum. In contrast,
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Figure 2: BKCa𝛼 augments the apoptotic response to serum deprivation: a response which is amplified by ANXA5 knockdown. (a) Caspase-
3/7 activity in wild type HEK 293 cells was quantified as relative luminescence units at 24 h and 48 h. Apoptosis was induced by serum
deprivation at time = 0 h, with and without ANXA5 knockdown using siRNA (shown beneath the bars). (b) As (a), but using BKCa𝛼HEK239
cells. Asterisks indicate that, after 48 h, ANXA5 knockdown enhanced the serum-deprived-evoked caspase activation (𝑝 < 0.05, 𝑛 = 3). (c)
Immunocytochemistry using an antibody directed against ANXA5 in BKCa𝛼 expressing HEK 293 cells following treatment with control (left)
and ANXA5 (right) siRNA. (d) Time course of caspase-3/7 activity, BKCa𝛼HEK 293 cells (± ANXA5 knockdown) incubated in the presence
of normal medium (control), or serum-deprived media (8% Mannitol, DMEM), over a 48-hour period.
Table 1: Ca2+ concentration-response EC
50
values for BKCa𝛼 channel of the control, ANXA5 siRNA knockdown, andANXA5 overexpression
models.
Control (𝑛 = 8) ANXA5 siRNA knockdown (𝑛 = 8) ANXA5 overexpression (𝑛 = 8)
𝐼/𝐼max at +60mV Va50 (mV) 𝐼/𝐼max at +60mV Va50 (mV) 𝐼/𝐼max at +60mV Va50 (mV)
EC
50
[Ca2+] (𝜇M) 1.79 ± 0.57 2.07 ± 0.39 0.53 ± 0.09∗ 0.62 ± 0.07∗ 3.58 ± 0.48∗ 4.42 ± 0.65∗
∗The values were considered as significantly different from the respective values of the control (𝑝 > 0.05).
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Figure 3: BKCa𝛼 subunit colocalizes with ANXA5. (a) Reciprocal coimmunoprecipitation from lysates of HEK 293 cells stably expressing
BKCa𝛼 subunit with anti-BKCa𝛼 antibody (+). Bead controls (−) consisted of lysate mixed with DynaG beads lacking antibody. (b) Reciprocal
coimmunoprecipitation from lysates of HEK 293 cells stably expressing BKCa𝛼 subunit with and anti-ANXA5 antibody (+) and bead control
(−). (c) HEK 293 cells stably expressing BKCa𝛼 subunit were immunostained with anti-BKCa𝛼 subunit (1 : 250, red) and anti-ANXA5 (1 : 200
green) antibodies and cell nuclei (blue) where visualized with DAPI. Scale bars are 50𝜇M.
Table 2: Normalized current (𝐼/𝐼max) at 60mV and Va50 values for BKCa𝛼 channel of the control, ANXA5 siRNA knockdown, and ANXA5
overexpression models.
Control (𝑛 = 8) ANXA5 siRNA knockdown (𝑛 = 8) ANXA5 overexpression (𝑛 = 8)
𝐼/𝐼max at +60mV Va50 (mV) 𝐼/𝐼max at +60mV Va50 (mV) 𝐼/𝐼max at +60mV Va50 (mV)
[Ca2+] 300 nM 0.25 ± 0.07 74.5 ± 4.6 0.38 ± 0.07 67.5 ± 2.8 0.19 ± 0.05∗ 79.5 ± 3.8∗
CORM-2 30𝜇M 0.61 ± 0.1 55.9 ± 5.2 0.79 ± 0.06 44.1 ± 2.7 0.51 ± 0.06∗ 57.5 ± 2.5∗
[Ca2+] 1 𝜇M 0.44 ± 0.08 60.0 ± 3.9 0.58 ± 0.10 54.8 ± 6.3 0.28 ± 0.03∗ 73.2 ± 2.7∗
∗The values were considered as significantly different from the respective values of ANXA5 siRNA knockdown (𝑝 > 0.05).
when cells are exposed to the serum deprivation, two impor-
tant processes are initiated. Firstly, [Ca2+]i runs up and
activates BKCa𝛼 [6, 7]. Secondly, ANXA5, which is associated
with the phosphatidylserine, flips to the outer membrane
leaflet, resulting in uncoupling of BKCa𝛼 /ANXA5 physical
interaction and a consequent progressive increase of Ca2+
sensitivity of BKCa𝛼. This augments BKCa𝛼 activity and
results in an amplified K+ efflux which accelerates AVD,
caspase activation, and cell death.This scheme is represented
pictorially in Figure 5.
Although these experiments have been conducted in a
heterologous expression system, they provide conception for
how we view the control of apoptosis in a variety of tissues
which express BKCa channels at a high level. For example,
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Figure 4: BKCa𝛼 channel function is modulated by its interaction with ANXA5 at different concentrations of Ca
2+. (a) Time course showing
the stimulatory effect of 30 𝜇M CORM-2 and the sequential increase of [Ca2+] in the concentration range 10 nM–1mM on BKCa𝛼 subunit
channel normalized current and Va
50
in the control (black line), in the ANXA5 knockdown model achieved by transfection with siRNA
(dark grey line), and in the ANXA5 overexpression model achieved by transfection with the DNA plasmid (light grey line). (b) Mean (±
SEM) concentration-response plots displaying the stimulation effect of the sequential increase of [Ca2+] in the concentration range 10 nM–
1mM on BKCa𝛼 channel normalized current at the holding voltage of 60mV in the wild type (black square and a solid black line, 𝑛 = 8), in
the ANXA5 knockdown model achieved by transfection with siRNA (grey circle and a solid grey line, 𝑛 = 8), in the ANXA5 overexpression
model achieved by transfection with ANXA5 DNA plasmid (light grey triangle and a solid light grey line, 𝑛 = 8), on Va
50
of BKCa𝛼 channels
in the wild type (white square and a dashed black line, 𝑛 = 8), in the ANXA5 knockdown model achieved by transfection with siRNA (white
circle and a dashed grey line, 𝑛 = 8), and in the ANXA5 overexpression model achieved by transfection with ANXA5 DNA plasmid (white
triangle and a dashed light grey line, 𝑛 = 8).
apoptosis is an important component of normal brain devel-
opment and in the cerebellum such programmed cell death
occurs in different cell layers at different points of pre- and
postnatal development. Indeed, the level of apoptosis in the
external granule cell layer gradually increases from week 26
until birth, whilst cells in the Purkinje layer only start to die
postnatally [33, 34]. Such patterns of apoptosis can be modu-
lated by extrinsic factors. For example, Purkinje cell apoptosis
is enhanced in utero during fetal alcohol syndrome [35]. Since
BKCa𝛼 channels are expressed in Purkinje neurones [36] and
their activity is known to be augmented by ethanol [37], it
seems likely that alcohol-evoked increases in BKCa𝛼 activity
may contribute to the enhanced apoptosis observed in this
neuronal cell layer.
Therefore, the data of this study show that the physi-
cal partnership of ANXA5 and BKCa𝛼 channels results in
decreased Ca2+ sensitivity of the latter under conditions close
to the physiological.The proposedmechanismmay be partic-
ularly important for the programmed cell death mechanism,
where membrane flippage removes the ANXA5 from the
vicinity of the intracellular C-terminal of BKCa𝛼, resulting in
augmentation of K+ efflux and subsequent apoptosis.
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